News & Notes

  • Emory Start-up: Metaclipse Therapeutics receive NIH grant to develop breast cancer vaccine ... View More
  • Emory Start-up: AKESOgen on Annual List of Fastest-Growing Private Companies for 2nd Consecutive Year ... View More
  • Emory Licensee: Blue Earth Diagnostics receives FDA approval for Fluciclovine ... View More
  • Emory Start-up: Clearside Biomedical goes public ... View More
  • OTT Announcement: TechFeed: sign up to receive our newest technologies based on your preferences ... View More

Featured Innovation

New Antibodies for Treating IBD

Charles Parkos, MD, PhD

Approximately 1.4 million Americans today suffer from chronic inflammation of the digestive tract (IBD) typically causing symptoms of diarrhea, severe abdominal pain, and weight loss. The interaction between white blood cells and the lining of the intestine damage the lining creating leaks. Anti-JAML antibodies hold promise in improving treatments.

IBD graphic

View More

Recent Twitter Posts